Fresenius reported €16.9B in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Akzo Nobel AKZA:NA 5.49B 318M
AstraZeneca AZN:LN 27.27B 8.54B
BASF BAS:GR 33.12B 1.5B
Bayer BAYN:GR 32.45B 3.35B
Davita Healthcare Partners DVA:US $ 3978.59M 111.9M
DSM DSM:NA € 5425M 880M
E.ON EOAN:GR 23.15B 948M
Fresenius FRE:GR € 16901M 208M
Fresenius Medical Care FME:GR € 7815M 26M
Fresenius Medical Care FMS:US $ 7815M 25.59M
Getinge GETIB:SS 14B 2.43B
Givaudan GIVN:VX 3.61B 307M
GlaxoSmithKline GSK:LN 17.57B 958M
GN Store Nord GN:DC 6.66B 38M
GRIFOLS GRF:SM € 3239.5M 153.93M
Hikma Pharmaceutical HIK:LN 1.96B 33M
Lonza Group LONN:SW 5.03B 229M
Merck MRK:GR € 10182M 435M
Novartis NOVN:VX 23.81B 1.61B
RWE RWE:GR € 49137M 20515M
William Demant Holding WDH:DC 7.49B 804M